Clinical Trials · NCT06344247
Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- RenJi Hospital
- Enrollment
- 48
- Start date
- Sep 2023
- Locations
- 1 site, China
- Primary endpoint
- Change of 24-hour urine protein quantification